Previous studies have demonstrated that celecoxib at high concentrations can suppress aromatase activity [29] and reduce estradiol amount [30] in the cultured breast cancer cells SK-BR-3 and MCF-7/Cox-2 clone. Here, CYP19A1 is linked to breast cancer.